<!DOCTYPE html>
<html>
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
  <title>FPADMET.html</title>
  <meta name="generator" content="Haroopad 0.13.1" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0">

  <style>div.oembedall-githubrepos{border:1px solid #DDD;border-radius:4px;list-style-type:none;margin:0 0 10px;padding:8px 10px 0;font:13.34px/1.4 helvetica,arial,freesans,clean,sans-serif;width:452px;background-color:#fff}div.oembedall-githubrepos .oembedall-body{background:-moz-linear-gradient(center top,#FAFAFA,#EFEFEF);background:-webkit-gradient(linear,left top,left bottom,from(#FAFAFA),to(#EFEFEF));border-bottom-left-radius:4px;border-bottom-right-radius:4px;border-top:1px solid #EEE;margin-left:-10px;margin-top:8px;padding:5px 10px;width:100%}div.oembedall-githubrepos h3{font-size:14px;margin:0;padding-left:18px;white-space:nowrap}div.oembedall-githubrepos p.oembedall-description{color:#444;font-size:12px;margin:0 0 3px}div.oembedall-githubrepos p.oembedall-updated-at{color:#888;font-size:11px;margin:0}div.oembedall-githubrepos ul.oembedall-repo-stats{border:none;float:right;font-size:11px;font-weight:700;padding-left:15px;position:relative;z-index:5;margin:0}div.oembedall-githubrepos ul.oembedall-repo-stats li{border:none;color:#666;display:inline-block;list-style-type:none;margin:0!important}div.oembedall-githubrepos ul.oembedall-repo-stats li a{background-color:transparent;border:none;color:#666!important;background-position:5px -2px;background-repeat:no-repeat;border-left:1px solid #DDD;display:inline-block;height:21px;line-height:21px;padding:0 5px 0 23px}div.oembedall-githubrepos ul.oembedall-repo-stats li:first-child a{border-left:medium none;margin-right:-3px}div.oembedall-githubrepos ul.oembedall-repo-stats li a:hover{background:5px -27px no-repeat #4183C4;color:#FFF!important;text-decoration:none}div.oembedall-githubrepos ul.oembedall-repo-stats li:first-child a:hover{border-bottom-left-radius:3px;border-top-left-radius:3px}ul.oembedall-repo-stats li:last-child a:hover{border-bottom-right-radius:3px;border-top-right-radius:3px}span.oembedall-closehide{background-color:#aaa;border-radius:2px;cursor:pointer;margin-right:3px}div.oembedall-container{margin-top:5px;text-align:left}.oembedall-ljuser{font-weight:700}.oembedall-ljuser img{vertical-align:bottom;border:0;padding-right:1px}.oembedall-stoqembed{border-bottom:1px dotted #999;float:left;overflow:hidden;width:730px;line-height:1;background:#FFF;color:#000;font-family:Arial,Liberation Sans,DejaVu Sans,sans-serif;font-size:80%;text-align:left;margin:0;padding:0}.oembedall-stoqembed a{color:#07C;text-decoration:none;margin:0;padding:0}.oembedall-stoqembed a:hover{text-decoration:underline}.oembedall-stoqembed a:visited{color:#4A6B82}.oembedall-stoqembed h3{font-family:Trebuchet MS,Liberation Sans,DejaVu Sans,sans-serif;font-size:130%;font-weight:700;margin:0;padding:0}.oembedall-stoqembed .oembedall-reputation-score{color:#444;font-size:120%;font-weight:700;margin-right:2px}.oembedall-stoqembed .oembedall-user-info{height:35px;width:185px}.oembedall-stoqembed .oembedall-user-info .oembedall-user-gravatar32{float:left;height:32px;width:32px}.oembedall-stoqembed .oembedall-user-info .oembedall-user-details{float:left;margin-left:5px;overflow:hidden;white-space:nowrap;width:145px}.oembedall-stoqembed .oembedall-question-hyperlink{font-weight:700}.oembedall-stoqembed .oembedall-stats{background:#EEE;margin:0 0 0 7px;padding:4px 7px 6px;width:58px}.oembedall-stoqembed .oembedall-statscontainer{float:left;margin-right:8px;width:86px}.oembedall-stoqembed .oembedall-votes{color:#555;padding:0 0 7px;text-align:center}.oembedall-stoqembed .oembedall-vote-count-post{font-size:240%;color:#808185;display:block;font-weight:700}.oembedall-stoqembed .oembedall-views{color:#999;padding-top:4px;text-align:center}.oembedall-stoqembed .oembedall-status{margin-top:-3px;padding:4px 0;text-align:center;background:#75845C;color:#FFF}.oembedall-stoqembed .oembedall-status strong{color:#FFF;display:block;font-size:140%}.oembedall-stoqembed .oembedall-summary{float:left;width:635px}.oembedall-stoqembed .oembedall-excerpt{line-height:1.2;margin:0;padding:0 0 5px}.oembedall-stoqembed .oembedall-tags{float:left;line-height:18px}.oembedall-stoqembed .oembedall-tags a:hover{text-decoration:none}.oembedall-stoqembed .oembedall-post-tag{background-color:#E0EAF1;border-bottom:1px solid #3E6D8E;border-right:1px solid #7F9FB6;color:#3E6D8E;font-size:90%;line-height:2.4;margin:2px 2px 2px 0;padding:3px 4px;text-decoration:none;white-space:nowrap}.oembedall-stoqembed .oembedall-post-tag:hover{background-color:#3E6D8E;border-bottom:1px solid #37607D;border-right:1px solid #37607D;color:#E0EAF1}.oembedall-stoqembed .oembedall-fr{float:right}.oembedall-stoqembed .oembedall-statsarrow{background-image:url(http://cdn.sstatic.net/stackoverflow/img/sprites.png?v=3);background-repeat:no-repeat;overflow:hidden;background-position:0 -435px;float:right;height:13px;margin-top:12px;width:7px}.oembedall-facebook1{border:1px solid #1A3C6C;padding:0;font:13.34px/1.4 verdana;width:500px}.oembedall-facebook2{background-color:#627add}.oembedall-facebook2 a{color:#e8e8e8;text-decoration:none}.oembedall-facebookBody{background-color:#fff;vertical-align:top;padding:5px}.oembedall-facebookBody .contents{display:inline-block;width:100%}.oembedall-facebookBody div img{float:left;margin-right:5px}div.oembedall-lanyard{-webkit-box-shadow:none;-webkit-transition-delay:0s;-webkit-transition-duration:.4000000059604645s;-webkit-transition-property:width;-webkit-transition-timing-function:cubic-bezier(0.42,0,.58,1);background-attachment:scroll;background-clip:border-box;background-color:transparent;background-image:none;background-origin:padding-box;border-width:0;box-shadow:none;color:#112644;display:block;float:left;font-family:'Trebuchet MS',Trebuchet,sans-serif;font-size:16px;height:253px;line-height:19px;margin:0;max-width:none;min-height:0;outline:#112644 0;overflow-x:visible;overflow-y:visible;padding:0;position:relative;text-align:left;vertical-align:baseline;width:804px}div.oembedall-lanyard .tagline{font-size:1.5em}div.oembedall-lanyard .wrapper{overflow:hidden;clear:both}div.oembedall-lanyard .split{float:left;display:inline}div.oembedall-lanyard .prominent-place .flag:active,div.oembedall-lanyard .prominent-place .flag:focus,div.oembedall-lanyard .prominent-place .flag:hover,div.oembedall-lanyard .prominent-place .flag:link,div.oembedall-lanyard .prominent-place .flag:visited{float:left;display:block;width:48px;height:48px;position:relative;top:-5px;margin-right:10px}div.oembedall-lanyard .place-context{font-size:.889em}div.oembedall-lanyard .prominent-place .sub-place{display:block}div.oembedall-lanyard .prominent-place{font-size:1.125em;line-height:1.1em;font-weight:400}div.oembedall-lanyard .main-date{color:#8CB4E0;font-weight:700;line-height:1.1}div.oembedall-lanyard .first{width:48.57%;margin:0 0 0 2.857%}.mermaid .label{color:#333}.node circle,.node polygon,.node rect{fill:#cde498;stroke:#13540c;stroke-width:1px}.edgePath .path{stroke:green;stroke-width:1.5px}.cluster rect{fill:#cdffb2;rx:40;stroke:#6eaa49;stroke-width:1px}.cluster text{fill:#333}.actor{stroke:#13540c;fill:#cde498}text.actor{fill:#000;stroke:none}.actor-line{stroke:grey}.messageLine0{stroke-width:1.5;stroke-dasharray:"2 2";marker-end:"url(#arrowhead)";stroke:#333}.messageLine1{stroke-width:1.5;stroke-dasharray:"2 2";stroke:#333}#arrowhead{fill:#333}#crosshead path{fill:#333!important;stroke:#333!important}.messageText{fill:#333;stroke:none}.labelBox{stroke:#326932;fill:#cde498}.labelText,.loopText{fill:#000;stroke:none}.loopLine{stroke-width:2;stroke-dasharray:"2 2";marker-end:"url(#arrowhead)";stroke:#326932}.note{stroke:#6eaa49;fill:#fff5ad}.noteText{fill:#000;stroke:none;font-family:'trebuchet ms',verdana,arial;font-size:14px}.section{stroke:none;opacity:.2}.section0,.section2{fill:#6eaa49}.section1,.section3{fill:#fff;opacity:.2}.sectionTitle0,.sectionTitle1,.sectionTitle2,.sectionTitle3{fill:#333}.sectionTitle{text-anchor:start;font-size:11px;text-height:14px}.grid .tick{stroke:lightgrey;opacity:.3;shape-rendering:crispEdges}.grid path{stroke-width:0}.today{fill:none;stroke:red;stroke-width:2px}.task{stroke-width:2}.taskText{text-anchor:middle;font-size:11px}.taskTextOutsideRight{fill:#000;text-anchor:start;font-size:11px}.taskTextOutsideLeft{fill:#000;text-anchor:end;font-size:11px}.taskText0,.taskText1,.taskText2,.taskText3{fill:#fff}.task0,.task1,.task2,.task3{fill:#487e3a;stroke:#13540c}.taskTextOutside0,.taskTextOutside1,.taskTextOutside2,.taskTextOutside3{fill:#000}.active0,.active1,.active2,.active3{fill:#cde498;stroke:#13540c}.activeText0,.activeText1,.activeText2,.activeText3{fill:#000!important}.done0,.done1,.done2,.done3{stroke:grey;fill:lightgrey;stroke-width:2}.doneText0,.doneText1,.doneText2,.doneText3{fill:#000!important}.crit0,.crit1,.crit2,.crit3{stroke:#f88;fill:red;stroke-width:2}.activeCrit0,.activeCrit1,.activeCrit2,.activeCrit3{stroke:#f88;fill:#cde498;stroke-width:2}.doneCrit0,.doneCrit1,.doneCrit2,.doneCrit3{stroke:#f88;fill:lightgrey;stroke-width:2;cursor:pointer;shape-rendering:crispEdges}.activeCritText0,.activeCritText1,.activeCritText2,.activeCritText3,.doneCritText0,.doneCritText1,.doneCritText2,.doneCritText3{fill:#000!important}.titleText{text-anchor:middle;font-size:18px;fill:#000}text{font-family:'trebuchet ms',verdana,arial;font-size:14px}html{height:100%}body{margin:0!important;padding:5px 20px 26px!important;background-color:#fff;font-family:"Lucida Grande","Segoe UI","Apple SD Gothic Neo","Malgun Gothic","Lucida Sans Unicode",Helvetica,Arial,sans-serif;font-size:.9em;overflow-x:hidden;overflow-y:auto}br,h1,h2,h3,h4,h5,h6{clear:both}hr.page{background:url(data:image/png;base64,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) repeat-x;border:0;height:3px;padding:0}hr.underscore{border-top-style:dashed!important}body >:first-child{margin-top:0!important}img.plugin{box-shadow:0 1px 3px rgba(0,0,0,.1);border-radius:3px}iframe{border:0}figure{-webkit-margin-before:0;-webkit-margin-after:0;-webkit-margin-start:0;-webkit-margin-end:0}kbd{border:1px solid #aaa;-moz-border-radius:2px;-webkit-border-radius:2px;border-radius:2px;-moz-box-shadow:1px 2px 2px #ddd;-webkit-box-shadow:1px 2px 2px #ddd;box-shadow:1px 2px 2px #ddd;background-color:#f9f9f9;background-image:-moz-linear-gradient(top,#eee,#f9f9f9,#eee);background-image:-o-linear-gradient(top,#eee,#f9f9f9,#eee);background-image:-webkit-linear-gradient(top,#eee,#f9f9f9,#eee);background-image:linear-gradient(top,#eee,#f9f9f9,#eee);padding:1px 3px;font-family:inherit;font-size:.85em}.oembeded .oembed_photo{display:inline-block}img[data-echo]{margin:25px 0;width:100px;height:100px;background:url(../img/ajax.gif) center center no-repeat #fff}.spinner{display:inline-block;width:10px;height:10px;margin-bottom:-.1em;border:2px solid rgba(0,0,0,.5);border-top-color:transparent;border-radius:100%;-webkit-animation:spin 1s infinite linear;animation:spin 1s infinite linear}.spinner:after{content:'';display:block;width:0;height:0;position:absolute;top:-6px;left:0;border:4px solid transparent;border-bottom-color:rgba(0,0,0,.5);-webkit-transform:rotate(45deg);transform:rotate(45deg)}@-webkit-keyframes spin{to{-webkit-transform:rotate(360deg)}}@keyframes spin{to{transform:rotate(360deg)}}p.toc{margin:0!important}p.toc ul{padding-left:10px}p.toc>ul{padding:10px;margin:0 10px;display:inline-block;border:1px solid #ededed;border-radius:5px}p.toc li,p.toc ul{list-style-type:none}p.toc li{width:100%;padding:0;overflow:hidden}p.toc li a::after{content:"."}p.toc li a:before{content:"• "}p.toc h5{text-transform:uppercase}p.toc .title{float:left;padding-right:3px}p.toc .number{margin:0;float:right;padding-left:3px;background:#fff;display:none}input.task-list-item{margin-left:-1.62em}.markdown{font-family:"Hiragino Sans GB","Microsoft YaHei",STHeiti,SimSun,"Lucida Grande","Lucida Sans Unicode","Lucida Sans",'Segoe UI',AppleSDGothicNeo-Medium,'Malgun Gothic',Verdana,Tahoma,sans-serif;padding:20px}.markdown a{text-decoration:none;vertical-align:baseline}.markdown a:hover{text-decoration:underline}.markdown h1{font-size:2.2em;font-weight:700;margin:1.5em 0 1em}.markdown h2{font-size:1.8em;font-weight:700;margin:1.275em 0 .85em}.markdown h3{font-size:1.6em;font-weight:700;margin:1.125em 0 .75em}.markdown h4{font-size:1.4em;font-weight:700;margin:.99em 0 .66em}.markdown h5{font-size:1.2em;font-weight:700;margin:.855em 0 .57em}.markdown h6{font-size:1em;font-weight:700;margin:.75em 0 .5em}.markdown h1+p,.markdown h1:first-child,.markdown h2+p,.markdown h2:first-child,.markdown h3+p,.markdown h3:first-child,.markdown h4+p,.markdown h4:first-child,.markdown h5+p,.markdown h5:first-child,.markdown h6+p,.markdown h6:first-child{margin-top:0}.markdown hr{border:1px solid #ccc}.markdown p{margin:1em 0;word-wrap:break-word}.markdown ol{list-style-type:decimal}.markdown li{display:list-item;line-height:1.4em}.markdown blockquote{margin:1em 20px}.markdown blockquote>:first-child{margin-top:0}.markdown blockquote>:last-child{margin-bottom:0}.markdown blockquote cite:before{content:'\2014 \00A0'}.markdown .code{border-radius:3px;word-wrap:break-word}.markdown pre{border-radius:3px;word-wrap:break-word;border:1px solid #ccc;overflow:auto;padding:.5em}.markdown pre code{border:0;display:block}.markdown pre>code{font-family:Consolas,Inconsolata,Courier,monospace;font-weight:700;white-space:pre;margin:0}.markdown code{border-radius:3px;word-wrap:break-word;border:1px solid #ccc;padding:0 5px;margin:0 2px}.markdown img{max-width:100%}.markdown mark{color:#000;background-color:#fcf8e3}.markdown table{padding:0;border-collapse:collapse;border-spacing:0;margin-bottom:16px}.markdown table tr td,.markdown table tr th{border:1px solid #ccc;margin:0;padding:6px 13px}.markdown table tr th{font-weight:700}.markdown table tr th>:first-child{margin-top:0}.markdown table tr th>:last-child{margin-bottom:0}.markdown table tr td>:first-child{margin-top:0}.markdown table tr td>:last-child{margin-bottom:0}.github{padding:20px;font-family:"Helvetica Neue",Helvetica,"Hiragino Sans GB","Microsoft YaHei",STHeiti,SimSun,"Segoe UI",AppleSDGothicNeo-Medium,'Malgun Gothic',Arial,freesans,sans-serif;font-size:15px;background:#fff;line-height:1.6;-webkit-font-smoothing:antialiased}.github a{color:#3269a0}.github a:hover{color:#4183c4}.github h2{border-bottom:1px solid #e6e6e6;line-height:1.6}.github h6{color:#777}.github hr{border:1px solid #e6e6e6}.github pre>code{font-size:.9em;font-family:Consolas,Inconsolata,Courier,monospace}.github blockquote>code,.github h1>code,.github h2>code,.github h3>code,.github h4>code,.github h5>code,.github h6>code,.github li>code,.github p>code,.github td>code{background-color:rgba(0,0,0,.07);font-family:Consolas,"Liberation Mono",Menlo,Courier,monospace;font-size:85%;padding:.2em .5em;border:0}.github blockquote{border-left:4px solid #e6e6e6;padding:0 15px;font-style:italic}.github table{background-color:#fafafa}.github table tr td,.github table tr th{border:1px solid #e6e6e6}.github table tr:nth-child(2n){background-color:#f2f2f2}.hljs{display:block;overflow-x:auto;padding:.5em;background:#fdf6e3;color:#657b83;-webkit-text-size-adjust:none}.diff .hljs-header,.hljs-comment,.hljs-doctype,.hljs-javadoc,.hljs-pi,.lisp .hljs-string{color:#93a1a1}.css .hljs-tag,.hljs-addition,.hljs-keyword,.hljs-request,.hljs-status,.hljs-winutils,.method,.nginx .hljs-title{color:#859900}.hljs-command,.hljs-dartdoc,.hljs-hexcolor,.hljs-link_url,.hljs-number,.hljs-phpdoc,.hljs-regexp,.hljs-rules .hljs-value,.hljs-string,.hljs-tag .hljs-value,.tex .hljs-formula{color:#2aa198}.css .hljs-function,.hljs-built_in,.hljs-chunk,.hljs-decorator,.hljs-id,.hljs-identifier,.hljs-localvars,.hljs-title,.vhdl .hljs-literal{color:#268bd2}.hljs-attribute,.hljs-class .hljs-title,.hljs-constant,.hljs-link_reference,.hljs-parent,.hljs-type,.hljs-variable,.lisp .hljs-body,.smalltalk .hljs-number{color:#b58900}.css .hljs-pseudo,.diff .hljs-change,.hljs-attr_selector,.hljs-cdata,.hljs-header,.hljs-pragma,.hljs-preprocessor,.hljs-preprocessor .hljs-keyword,.hljs-shebang,.hljs-special,.hljs-subst,.hljs-symbol,.hljs-symbol .hljs-string{color:#cb4b16}.hljs-deletion,.hljs-important{color:#dc322f}.hljs-link_label{color:#6c71c4}.tex .hljs-formula{background:#eee8d5}.MathJax_Hover_Frame{border-radius:.25em;-webkit-border-radius:.25em;-moz-border-radius:.25em;-khtml-border-radius:.25em;box-shadow:0 0 15px #83A;-webkit-box-shadow:0 0 15px #83A;-moz-box-shadow:0 0 15px #83A;-khtml-box-shadow:0 0 15px #83A;border:1px solid #A6D!important;display:inline-block;position:absolute}.MathJax_Hover_Arrow{position:absolute;width:15px;height:11px;cursor:pointer}#MathJax_About{position:fixed;left:50%;width:auto;text-align:center;border:3px outset;padding:1em 2em;background-color:#DDD;color:#000;cursor:default;font-family:message-box;font-size:120%;font-style:normal;text-indent:0;text-transform:none;line-height:normal;letter-spacing:normal;word-spacing:normal;word-wrap:normal;white-space:nowrap;float:none;z-index:201;border-radius:15px;-webkit-border-radius:15px;-moz-border-radius:15px;-khtml-border-radius:15px;box-shadow:0 10px 20px gray;-webkit-box-shadow:0 10px 20px gray;-moz-box-shadow:0 10px 20px gray;-khtml-box-shadow:0 10px 20px gray;filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}.MathJax_Menu{position:absolute;background-color:#fff;color:#000;width:auto;padding:2px;border:1px solid #CCC;margin:0;cursor:default;font:menu;text-align:left;text-indent:0;text-transform:none;line-height:normal;letter-spacing:normal;word-spacing:normal;word-wrap:normal;white-space:nowrap;float:none;z-index:201;box-shadow:0 10px 20px gray;-webkit-box-shadow:0 10px 20px gray;-moz-box-shadow:0 10px 20px gray;-khtml-box-shadow:0 10px 20px gray;filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}.MathJax_MenuItem{padding:2px 2em;background:0 0}.MathJax_MenuArrow{position:absolute;right:.5em;color:#666}.MathJax_MenuActive .MathJax_MenuArrow{color:#fff}.MathJax_MenuArrow.RTL{left:.5em;right:auto}.MathJax_MenuCheck{position:absolute;left:.7em}.MathJax_MenuCheck.RTL{right:.7em;left:auto}.MathJax_MenuRadioCheck{position:absolute;left:1em}.MathJax_MenuRadioCheck.RTL{right:1em;left:auto}.MathJax_MenuLabel{padding:2px 2em 4px 1.33em;font-style:italic}.MathJax_MenuRule{border-top:1px solid #CCC;margin:4px 1px 0}.MathJax_MenuDisabled{color:GrayText}.MathJax_MenuActive{background-color:Highlight;color:HighlightText}.MathJax_Menu_Close{position:absolute;width:31px;height:31px;top:-15px;left:-15px}#MathJax_Zoom{position:absolute;background-color:#F0F0F0;overflow:auto;display:block;z-index:301;padding:.5em;border:1px solid #000;margin:0;font-weight:400;font-style:normal;text-align:left;text-indent:0;text-transform:none;line-height:normal;letter-spacing:normal;word-spacing:normal;word-wrap:normal;white-space:nowrap;float:none;box-shadow:5px 5px 15px #AAA;-webkit-box-shadow:5px 5px 15px #AAA;-moz-box-shadow:5px 5px 15px #AAA;-khtml-box-shadow:5px 5px 15px #AAA;filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}#MathJax_ZoomOverlay{position:absolute;left:0;top:0;z-index:300;display:inline-block;width:100%;height:100%;border:0;padding:0;margin:0;background-color:#fff;opacity:0;filter:alpha(opacity=0)}#MathJax_ZoomFrame{position:relative;display:inline-block;height:0;width:0}#MathJax_ZoomEventTrap{position:absolute;left:0;top:0;z-index:302;display:inline-block;border:0;padding:0;margin:0;background-color:#fff;opacity:0;filter:alpha(opacity=0)}.MathJax_Preview{color:#888}#MathJax_Message{position:fixed;left:1px;bottom:2px;background-color:#E6E6E6;border:1px solid #959595;margin:0;padding:2px 8px;z-index:102;color:#000;font-size:80%;width:auto;white-space:nowrap}#MathJax_MSIE_Frame{position:absolute;top:0;left:0;width:0;z-index:101;border:0;margin:0;padding:0}.MathJax_Error{color:#C00;font-style:italic}.MathJax_Display{text-align:center;margin:1em 0;position:relative;display:block!important;text-indent:0;max-width:none;max-height:none;min-width:0;min-height:0;width:100%}.MathJax .merror{background-color:#FF8;color:#C00;border:1px solid #C00;padding:1px 3px;font-style:normal;font-size:90%}.MathJax .MJX-monospace{font-family:monospace}.MathJax .MJX-sans-serif{font-family:sans-serif}#MathJax_Tooltip{background-color:InfoBackground;color:InfoText;border:1px solid #000;box-shadow:2px 2px 5px #AAA;-webkit-box-shadow:2px 2px 5px #AAA;-moz-box-shadow:2px 2px 5px #AAA;-khtml-box-shadow:2px 2px 5px #AAA;filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true');padding:3px 4px;z-index:401;position:absolute;left:0;top:0;width:auto;height:auto;display:none}.MathJax{display:inline;font-style:normal;font-weight:400;line-height:normal;font-size:100%;font-size-adjust:none;text-indent:0;text-align:left;text-transform:none;letter-spacing:normal;word-spacing:normal;word-wrap:normal;white-space:nowrap;float:none;direction:ltr;max-width:none;max-height:none;min-width:0;min-height:0;border:0;padding:0;margin:0}.MathJax a,.MathJax img,.MathJax nobr{border:0;padding:0;margin:0;max-width:5000em;max-height:5000em;min-width:0;min-height:0;vertical-align:0;line-height:normal;text-decoration:none}img.MathJax_strut{border:0!important;padding:0!important;margin:0!important;vertical-align:0!important}.MathJax span{display:inline;position:static;border:0;padding:0;margin:0;vertical-align:0;line-height:normal;text-decoration:none}.MathJax nobr{white-space:nowrap!important}.MathJax img{display:inline!important;float:none!important}.MathJax *{transition:none;-webkit-transition:none;-moz-transition:none;-ms-transition:none;-o-transition:none}.MathJax_Processing{visibility:hidden;position:fixed;width:0;height:0;overflow:hidden}.MathJax_Processed{display:none!important}.MathJax_ExBox{display:block!important;overflow:hidden;width:1px;height:60ex;min-height:0;max-height:none}.MathJax .MathJax_EmBox{display:block!important;overflow:hidden;width:1px;height:60em;min-height:0;max-height:none}.MathJax .MathJax_HitBox{cursor:text;background:#fff;opacity:0;filter:alpha(opacity=0)}#MathJax_Tooltip *,.MathJax .MathJax_HitBox *{filter:none;opacity:1;background:0 0}@font-face{font-family:MathJax_Main;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Main-Regular.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Main-Regular.otf?rev=2.4-beta-2) format('opentype')}@font-face{font-family:MathJax_Main;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Main-Bold.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Main-Bold.otf?rev=2.4-beta-2) format('opentype');font-weight:700}@font-face{font-family:MathJax_Main;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Main-Italic.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Main-Italic.otf?rev=2.4-beta-2) format('opentype');font-style:italic}@font-face{font-family:MathJax_Math;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Math-Italic.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Math-Italic.otf?rev=2.4-beta-2) format('opentype');font-style:italic}@font-face{font-family:MathJax_Caligraphic;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Caligraphic-Regular.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Caligraphic-Regular.otf?rev=2.4-beta-2) format('opentype')}@font-face{font-family:MathJax_Size1;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Size1-Regular.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Size1-Regular.otf?rev=2.4-beta-2) format('opentype')}@font-face{font-family:MathJax_Size2;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Size2-Regular.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Size2-Regular.otf?rev=2.4-beta-2) format('opentype')}@font-face{font-family:MathJax_Size3;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Size3-Regular.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Size3-Regular.otf?rev=2.4-beta-2) format('opentype')}@font-face{font-family:MathJax_Size4;src:url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/woff/MathJax_Size4-Regular.woff?rev=2.4-beta-2) format('woff'),url(file:///C:/Haroopad/Libraries/.js/MathJax/fonts/HTML-CSS/TeX/otf/MathJax_Size4-Regular.otf?rev=2.4-beta-2) format('opentype')}.MathJax .noError{font-size:90%;text-align:left;color:#000;padding:1px 3px;border:1px solid}footer{position:fixed;font-size:.8em;text-align:right;bottom:0;margin-left:-25px;height:20px;width:100%}</style>
</head>
<body class="markdown github">
<h1 id="admet-properties-studied"><a name="admet-properties-studied" href="#admet-properties-studied"></a>ADMET Properties Studied</h1><h2 id="anticommensal-effect-on-the-human-gut-microbiota-(hgm)"><a name="anticommensal-effect-on-the-human-gut-microbiota-(hgm)" href="#anticommensal-effect-on-the-human-gut-microbiota-(hgm)"></a>Anticommensal effect on the human gut microbiota (HGM)</h2><p>Some of the existing drugs that are designed to target human cells can notably alter the composition of the HGM. This anticommensal effect of the drugs should therefore be avoided.</p><h2 id="blood-brain-barrier-permeability"><a name="blood-brain-barrier-permeability" href="#blood-brain-barrier-permeability"></a>Blood Brain Barrier Permeability</h2><p>Diffusion of drugs across blood brain barrier (endothelium separating the blood from the central nervous system) is quite restrictive. Early assessment<br>of BBB permeation is therefore of great importance, not only for CNS-active agents, but also for drugs that must be forbidden entry into the CNS (to prevent harmful side effects).</p><h2 id="breast-cancer-resistance-protein-inhibition"><a name="breast-cancer-resistance-protein-inhibition" href="#breast-cancer-resistance-protein-inhibition"></a>Breast Cancer Resistance Protein Inhibition</h2><p>The Breast Cancer Resistance Protein (BCRP) is seen to responsible for the multidrug resistance phenomenon observed in some cancers and is also involved in drug-drug interactions in the liver. Identification of potent and selective<br>inhibitors of BCRP is therefore of great interest to medicinal chemistry groups. </p><h2 id="human-oral-bioavailability"><a name="human-oral-bioavailability" href="#human-oral-bioavailability"></a>Human Oral bioavailability</h2><p>The oral bioavailability (an important pharmacokinetic property) measures the extent to which the active moiety is absorbed and becomes available in the systemic circulation. Since most drugs are administered orally, bioavailability decreases and methods that can differentiate between high and low bioavailability can help reduce undesirable attrition.</p><h2 id="cyp450-metabolism"><a name="cyp450-metabolism" href="#cyp450-metabolism"></a>CYP450 Metabolism</h2><p>The cytochrome P450 superfamily oxidize steroids, fatty acids, and xenobiotics, and are important for the clearance of various compounds. Adverse side effects of drug–drug interactions induced by human CYP450 inhibition is a major cause for concern. Here the models predict inhibition f five major CYP450 isoforms, namely, 1A2, 2C9, 2C19, 2D6, and 3A4.</p><h2 id="dmso-solubility"><a name="dmso-solubility" href="#dmso-solubility"></a>DMSO Solubility</h2><p>Solubility of drugs in Dimethyl Sulfoxide is an important parameter considered by pharmaceutical companies. Nonsoluble compunds cannot be used in automatized high-throughput screening (HTS) and  thus experimental measurements cannot be obtained for such compounds.</p><h2 id="fraction-unbound-in-human-plasma"><a name="fraction-unbound-in-human-plasma" href="#fraction-unbound-in-human-plasma"></a>Fraction Unbound in Human Plasma</h2><p>The fraction unbound in plasma is an important determinant of drug efficacy in pharmacokinetic and pharmacodynamic studies.</p><h2 id="fraction-unbound-in-brain"><a name="fraction-unbound-in-brain" href="#fraction-unbound-in-brain"></a>Fraction Unbound in Brain</h2><p>Knowing the value of the unbound drug fraction in the brain is essential in estimating its effects and toxicity on the central nervous system.</p><h2 id="human-intestinal-absorption"><a name="human-intestinal-absorption" href="#human-intestinal-absorption"></a>Human Intestinal Absorption</h2><p>Human intestinal absorption (HIA) is an alternative indicator for oral bioavailability to some extent and thus plays an important role in preclinical drug evaluation. A HIA value of 30% was used as the criterion to divide chemical agents into the good absorption (Positive) and the poor-absorption (Negative) classes.</p><h2 id="human-liver-microsomal-clearance"><a name="human-liver-microsomal-clearance" href="#human-liver-microsomal-clearance"></a>Human Liver Microsomal Clearance</h2><p>Microsomal lability assays are widely employed in drug discovery to identify compounds that will have desirable pharmacokinetics in humans. Here models have been established to predict the microsomal lability in different species: rat, mouse and humans.</p><h2 id="human-liver-microsomal-stability"><a name="human-liver-microsomal-stability" href="#human-liver-microsomal-stability"></a>Human Liver Microsomal Stability</h2><p>The human liver microsomal (HLM) stability assay is commonly used for assessing clearance of  chemicals by the human liver. Here, a <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-1-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-1" style="width: 2.017em; display: inline-block;"><span style="display: inline-block; position: relative; width: 1.667em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.448em 1000em 3.052em -0.479em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-2"><span class="mi" id="MathJax-Span-3" style="font-family: MathJax_Math; font-style: italic;">T<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.12em;"></span></span><span class="mfrac" id="MathJax-Span-4" style="padding-left: 0.167em;"><span style="display: inline-block; position: relative; width: 0.509em; height: 0px; margin-right: 0.12em; margin-left: 0.12em;"><span style="position: absolute; clip: rect(1.64em 1000em 2.444em -0.441em); top: -2.692em; left: 50%; margin-left: -0.194em;"><span class="mn" id="MathJax-Span-5" style="font-size: 70.7%; font-family: MathJax_Main;">1</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span><span style="position: absolute; clip: rect(1.64em 1000em 2.444em -0.465em); top: -1.893em; left: 50%; margin-left: -0.194em;"><span class="mn" id="MathJax-Span-6" style="font-size: 70.7%; font-family: MathJax_Main;">2</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span><span style="position: absolute; clip: rect(0.819em 1000em 1.222em -0.5em); top: -1.276em; left: 0em;"><span style="border-left-width: 0.509em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.25px; vertical-align: 0em;"></span><span style="display: inline-block; width: 0px; height: 1.056em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.658em; vertical-align: -0.529em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-1">T\frac{1}{2}</script></span> of 30 min was used to categorize a compound as stable (<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-2-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-7" style="width: 4.817em; display: inline-block;"><span style="display: inline-block; position: relative; width: 4em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.67em 1000em 3.274em -0.479em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-8"><span class="mi" id="MathJax-Span-9" style="font-family: MathJax_Math; font-style: italic;">T<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.12em;"></span></span><span class="mfrac" id="MathJax-Span-10" style="padding-left: 0.167em;"><span style="display: inline-block; position: relative; width: 0.509em; height: 0px; margin-right: 0.12em; margin-left: 0.12em;"><span style="position: absolute; clip: rect(1.64em 1000em 2.444em -0.441em); top: -2.692em; left: 50%; margin-left: -0.194em;"><span class="mn" id="MathJax-Span-11" style="font-size: 70.7%; font-family: MathJax_Main;">1</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span><span style="position: absolute; clip: rect(1.64em 1000em 2.444em -0.465em); top: -1.893em; left: 50%; margin-left: -0.194em;"><span class="mn" id="MathJax-Span-12" style="font-size: 70.7%; font-family: MathJax_Main;">2</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span><span style="position: absolute; clip: rect(0.819em 1000em 1.222em -0.5em); top: -1.276em; left: 0em;"><span style="border-left-width: 0.509em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.25px; vertical-align: 0em;"></span><span style="display: inline-block; width: 0px; height: 1.056em;"></span></span></span></span><span class="mo" id="MathJax-Span-13" style="font-family: MathJax_Main; padding-left: 0.278em;">&gt;</span><span class="mn" id="MathJax-Span-14" style="font-family: MathJax_Main; padding-left: 0.278em;">30</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.658em; vertical-align: -0.529em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-2">T\frac{1}{2} > 30</script></span> min) or unstable (<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-3-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-15" style="width: 4.817em; display: inline-block;"><span style="display: inline-block; position: relative; width: 4em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.67em 1000em 3.274em -0.479em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-16"><span class="mi" id="MathJax-Span-17" style="font-family: MathJax_Math; font-style: italic;">T<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.12em;"></span></span><span class="mfrac" id="MathJax-Span-18" style="padding-left: 0.167em;"><span style="display: inline-block; position: relative; width: 0.509em; height: 0px; margin-right: 0.12em; margin-left: 0.12em;"><span style="position: absolute; clip: rect(1.64em 1000em 2.444em -0.441em); top: -2.692em; left: 50%; margin-left: -0.194em;"><span class="mn" id="MathJax-Span-19" style="font-size: 70.7%; font-family: MathJax_Main;">1</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span><span style="position: absolute; clip: rect(1.64em 1000em 2.444em -0.465em); top: -1.893em; left: 50%; margin-left: -0.194em;"><span class="mn" id="MathJax-Span-20" style="font-size: 70.7%; font-family: MathJax_Main;">2</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span><span style="position: absolute; clip: rect(0.819em 1000em 1.222em -0.5em); top: -1.276em; left: 0em;"><span style="border-left-width: 0.509em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.25px; vertical-align: 0em;"></span><span style="display: inline-block; width: 0px; height: 1.056em;"></span></span></span></span><span class="mo" id="MathJax-Span-21" style="font-family: MathJax_Main; padding-left: 0.278em;">≤</span><span class="mn" id="MathJax-Span-22" style="font-family: MathJax_Main; padding-left: 0.278em;">30</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.658em; vertical-align: -0.529em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-3">T\frac{1}{2} \leq 30</script></span> min) in an HLM assay.</p><h2 id="hepatocellular-organic-anion-transporting-polypeptide-inhibition"><a name="hepatocellular-organic-anion-transporting-polypeptide-inhibition" href="#hepatocellular-organic-anion-transporting-polypeptide-inhibition"></a>Hepatocellular organic anion transporting polypeptide Inhibition</h2><p>Hepatocellular organic anion transporting polypeptides (OATP1B1, OATP1B3, and OATP2B1) are important for liver function and the regulation of the drug elimination process. OATP1B inhibition or induction may be the underlying mechanism of clinically relevant drug-drug interactions. Goal is to build models that can predict hepatic OATP inhibitory capacity of new molecules.</p><h2 id="drug-affinity-to-human-serum-albumin"><a name="drug-affinity-to-human-serum-albumin" href="#drug-affinity-to-human-serum-albumin"></a>Drug affinity to Human Serum Albumin</h2><p>Human serum albumin (HSA) is the most abundant protein in human blood plasma. Binding of drugs to HSA strongly influences their pharmacokinetic behaviour and is associated with drug-drug interactions and drug safety. The model predicts <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-4-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-23" style="width: 5.617em; display: inline-block;"><span style="display: inline-block; position: relative; width: 4.667em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.84em 1000em 3.095em -0.474em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-24"><span class="mi" id="MathJax-Span-25" style="font-family: MathJax_Main;">log</span><span class="mo" id="MathJax-Span-26"></span><span class="mi" id="MathJax-Span-27" style="font-family: MathJax_Math; font-style: italic; padding-left: 0.167em;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.04em;"></span></span><span class="mi" id="MathJax-Span-28" style="font-family: MathJax_Math; font-style: italic;">H<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.057em;"></span></span><span class="mi" id="MathJax-Span-29" style="font-family: MathJax_Math; font-style: italic;">S<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.032em;"></span></span><span class="mi" id="MathJax-Span-30" style="font-family: MathJax_Math; font-style: italic;">A</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.24em; vertical-align: -0.314em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-4">\log KHSA</script></span>: the binding constant obtained from the retention time on an immobilized HSA column using affinity chromatography.</p><h2 id="drug-interactions-with-the-human-bile-salt-export-pump"><a name="drug-interactions-with-the-human-bile-salt-export-pump" href="#drug-interactions-with-the-human-bile-salt-export-pump"></a>Drug Interactions With the Human Bile Salt Export Pump</h2><p>Drug-induced liver injury is frequently associated with inhibition of bile salt transporters such as the bile salt export pump (BSEP) which is mainly expressed in the liver. The model predicts BSEP inhibition.</p><h2 id="drug-transport-across-the-human-placenta-barrier"><a name="drug-transport-across-the-human-placenta-barrier" href="#drug-transport-across-the-human-placenta-barrier"></a>Drug transport across the human placenta barrier</h2><p>The human placental barrier permeability of drugs is essential for drug safety during pregnancy. The regression model predicts placental transfer expressed by clearance index values.</p><h2 id="*in-vivo*-intrinsic-clearance"><a name="*in-vivo*-intrinsic-clearance" href="#*in-vivo*-intrinsic-clearance"></a><em>in Vivo</em> Intrinsic Clearance</h2><p>Hepatic metabolism is a key determinant for drug clearance. Predicting the intrinsic metabolic clearance CL<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-5-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-31" style="width: 1.283em; display: inline-block;"><span style="display: inline-block; position: relative; width: 1.056em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.683em 1000em 2.491em -0.5em); top: -2.167em; left: 0em;"><span class="mrow" id="MathJax-Span-32"><span class="msubsup" id="MathJax-Span-33"><span style="display: inline-block; position: relative; width: 1.019em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-34"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -2.128em; left: 0em;"><span class="texatom" id="MathJax-Span-35"><span class="mrow" id="MathJax-Span-36"><span class="mi" id="MathJax-Span-37" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-38" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">n</span><span class="mi" id="MathJax-Span-39" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">t</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.704em; vertical-align: -0.256em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-5">_{int}</script></span> would go a long way in assessing drug safety and pharmacodynamics. The CL<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-6-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-40" style="width: 1.283em; display: inline-block;"><span style="display: inline-block; position: relative; width: 1.056em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.683em 1000em 2.491em -0.5em); top: -2.167em; left: 0em;"><span class="mrow" id="MathJax-Span-41"><span class="msubsup" id="MathJax-Span-42"><span style="display: inline-block; position: relative; width: 1.019em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-43"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -2.128em; left: 0em;"><span class="texatom" id="MathJax-Span-44"><span class="mrow" id="MathJax-Span-45"><span class="mi" id="MathJax-Span-46" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-47" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">n</span><span class="mi" id="MathJax-Span-48" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">t</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.704em; vertical-align: -0.256em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-6">_{int}</script></span> data were negative-log<br>transformed prior to modeling.</p><h2 id="logd"><a name="logd" href="#logd"></a>logD</h2><p>The lipophilicity at pH = 7.4 (the physiological pH of blood serum), is a major determinant of various  ADMET parameters of drug candidates. It is said to be a  better descriptor of the lipophilicity of a molecule.</p><h2 id="logs"><a name="logs" href="#logs"></a>logS</h2><p>The aqueous solubility of compounds has a key role in various domains. The database AqSolDB contains experimental solubility values that were all standardized to the LogS units. Compounds can be classified according to solubility values (LogS):</p><ol>
<li>Compounds with 0 and higher solubility value are highly soluble</li><li>Those in the range of 0 to −2 are soluble</li><li>Those in the range of −2 to −4 are slightly soluble</li><li>Insoluble if less than −4</li></ol><h2 id="madin-darby-canine-kidney-cell-line-permeability"><a name="madin-darby-canine-kidney-cell-line-permeability" href="#madin-darby-canine-kidney-cell-line-permeability"></a>Madin-Darby canine kidney cell line permeability</h2><h2 id="caco-2-permeability"><a name="caco-2-permeability" href="#caco-2-permeability"></a>CACO-2 Permeability</h2><p>The absorption of oral drugs occurs in the small intestine where the drug has to traverse the semipermeable intestinal columnar epithelial cells. <em>In vitro</em> permeability assays mimick the oral absorption process. Examples include Caco-2 (human colon adenocarcinoma), MDCK (Madin-Darby canine kidney). For MDCK, the model predicts MDCK permeability coefficients (apparent permeability, P<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-7-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-49" style="width: 1.483em; display: inline-block;"><span style="display: inline-block; position: relative; width: 1.222em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.837em 1000em 2.621em -0.5em); top: -2.167em; left: 0em;"><span class="mrow" id="MathJax-Span-50"><span class="msubsup" id="MathJax-Span-51"><span style="display: inline-block; position: relative; width: 1.186em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-52"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -2.128em; left: 0em;"><span class="texatom" id="MathJax-Span-53"><span class="mrow" id="MathJax-Span-54"><span class="mi" id="MathJax-Span-55" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">a</span><span class="mi" id="MathJax-Span-56" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">p</span><span class="mi" id="MathJax-Span-57" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">p</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.673em; vertical-align: -0.411em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-7">_{app}</script></span>).</p><h2 id="metabolic-intrinsic-clearance"><a name="metabolic-intrinsic-clearance" href="#metabolic-intrinsic-clearance"></a>Metabolic Intrinsic Clearance</h2><p>A key consideration at the screening stages of drug discovery is <em>in vitro</em> metabolic stability, often measured in human liver microsomes. Classification models were created for CL<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-8-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-58" style="width: 1.283em; display: inline-block;"><span style="display: inline-block; position: relative; width: 1.056em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.683em 1000em 2.491em -0.5em); top: -2.167em; left: 0em;"><span class="mrow" id="MathJax-Span-59"><span class="msubsup" id="MathJax-Span-60"><span style="display: inline-block; position: relative; width: 1.019em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-61"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -2.128em; left: 0em;"><span class="texatom" id="MathJax-Span-62"><span class="mrow" id="MathJax-Span-63"><span class="mi" id="MathJax-Span-64" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-65" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">n</span><span class="mi" id="MathJax-Span-66" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">t</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.704em; vertical-align: -0.256em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-8">_{int}</script></span> based on:</p><ol>
<li>stable if CL<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-9-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-67" style="width: 2.55em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.111em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(2.016em 1000em 3.047em -0.5em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-68"><span class="msubsup" id="MathJax-Span-69"><span style="display: inline-block; position: relative; width: 1.019em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-70"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -2.128em; left: 0em;"><span class="texatom" id="MathJax-Span-71"><span class="mrow" id="MathJax-Span-72"><span class="mi" id="MathJax-Span-73" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-74" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">n</span><span class="mi" id="MathJax-Span-75" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">t</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span><span class="mo" id="MathJax-Span-76" style="font-family: MathJax_Main; padding-left: 0.278em;">&lt;</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.971em; vertical-align: -0.256em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-9">_{int}<</script></span> 20 mL/min/mg, moderate</li><li>if <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-10-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-77" style="width: 9.283em; display: inline-block;"><span style="display: inline-block; position: relative; width: 7.722em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.851em 1000em 3.047em -0.45em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-78"><span class="mn" id="MathJax-Span-79" style="font-family: MathJax_Main;">20</span><span class="mo" id="MathJax-Span-80" style="font-family: MathJax_Main; padding-left: 0.278em;">&lt;</span><span class="mi" id="MathJax-Span-81" style="font-family: MathJax_Math; font-style: italic; padding-left: 0.278em;">C<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.045em;"></span></span><span class="msubsup" id="MathJax-Span-82"><span style="display: inline-block; position: relative; width: 1.742em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.468em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-83" style="font-family: MathJax_Math; font-style: italic;">L</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.722em;"><span class="texatom" id="MathJax-Span-84"><span class="mrow" id="MathJax-Span-85"><span class="mi" id="MathJax-Span-86" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-87" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">n</span><span class="mi" id="MathJax-Span-88" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">t</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span><span class="mo" id="MathJax-Span-89" style="font-family: MathJax_Main; padding-left: 0.278em;">&lt;</span><span class="mn" id="MathJax-Span-90" style="font-family: MathJax_Main; padding-left: 0.278em;">300</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.169em; vertical-align: -0.256em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-10">20 < CL_{int} < 300</script></span> mL/min/mg,</li><li>unstable if <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-11-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-91" style="width: 6.483em; display: inline-block;"><span style="display: inline-block; position: relative; width: 5.389em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.851em 1000em 3.047em -0.45em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-92"><span class="mi" id="MathJax-Span-93" style="font-family: MathJax_Math; font-style: italic;">C<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.045em;"></span></span><span class="msubsup" id="MathJax-Span-94"><span style="display: inline-block; position: relative; width: 1.742em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.468em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-95" style="font-family: MathJax_Math; font-style: italic;">L</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.722em;"><span class="texatom" id="MathJax-Span-96"><span class="mrow" id="MathJax-Span-97"><span class="mi" id="MathJax-Span-98" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-99" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">n</span><span class="mi" id="MathJax-Span-100" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">t</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span><span class="mo" id="MathJax-Span-101" style="font-family: MathJax_Main; padding-left: 0.278em;">≥</span><span class="mn" id="MathJax-Span-102" style="font-family: MathJax_Main; padding-left: 0.278em;">300</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.169em; vertical-align: -0.256em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-11">CL_{int} \geq 300</script></span> mL/min/mg</li></ol><h2 id="multidrug-and-toxin-extrusion-transporter-1-inhibition"><a name="multidrug-and-toxin-extrusion-transporter-1-inhibition" href="#multidrug-and-toxin-extrusion-transporter-1-inhibition"></a>Multidrug and Toxin Extrusion Transporter 1 Inhibition</h2><p>The human multidrug and toxin extrusion (MATE) transporter 1 contributes to the tissue distribution and excretion of many drugs. Inhibition of MATE1 can impact potential drug−drug interactions (DDIs) and cause alterations in drug exposure and accumulation in various tissues.</p><h2 id="organic-cation-transporter-2-inhibtion"><a name="organic-cation-transporter-2-inhibtion" href="#organic-cation-transporter-2-inhibtion"></a>Organic Cation Transporter 2 inhibtion</h2><p>The kidney represents an important site for drug-drug interactions. Most registered drugs are eliminated via the kidneys. Hepatic metabolism is usually<br>followed by renal excretion of the formed metabolites. Consequently, inhibition of renal drug transport can result in significantly altered systemic levels of the parent drug molecule and of potentially active metabolites, with ultimate effects on the drug’s pharmacological and toxicological profile.</p><h2 id="substrates/inhibitors-of-p-glycoprotein"><a name="substrates/inhibitors-of-p-glycoprotein" href="#substrates/inhibitors-of-p-glycoprotein"></a>Substrates/inhibitors of P-glycoprotein</h2><p>P-glycoprotein (P-gp) has significant impact on the multidrug resistance and pharmacokinetics of drugs. Compounds actively transported by P-gp are<br>classified as substrates, whereas those that compromise the transporting<br>function of P-gp are classified as inhibitors.</p><h2 id="prediction-of-$$pk_a$$"><a name="prediction-of-$$pk_a$$" href="#prediction-of-$$pk_a$$"></a>Prediction of <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-12-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-103" style="width: 2.283em; display: inline-block;"><span style="display: inline-block; position: relative; width: 1.889em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.861em -0.539em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-104"><span class="mi" id="MathJax-Span-105" style="font-family: MathJax_Math; font-style: italic;">p</span><span class="msubsup" id="MathJax-Span-106"><span style="display: inline-block; position: relative; width: 1.368em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.469em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-107" style="font-family: MathJax_Math; font-style: italic;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.04em;"></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.904em;"><span class="mi" id="MathJax-Span-108" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">a</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.186em; vertical-align: -0.299em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-12">pK_a</script></span></h2><p>The acid−base dissociation constant, pKa, is a key parameter to define the ionization state of a compound and directly affects its biopharmaceutical profile.</p><h2 id="human-plasma-protein-binding"><a name="human-plasma-protein-binding" href="#human-plasma-protein-binding"></a>human plasma protein binding</h2><p>Plasma protein binding (PPB) is a key player of drug ADME. Drugs with high PPB, especially those with a narrow therapeutic window, tend to be associated with safety issues and adverse effects. In order to determine the extent of PPB of new drug candidates, the data was divided into three sets of:</p><ol>
<li>high binding level (PPB<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-13-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-109" style="width: 1.017em; display: inline-block;"><span style="display: inline-block; position: relative; width: 0.833em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(2.016em 1000em 2.929em -0.417em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-110"><span class="mo" id="MathJax-Span-111" style="font-family: MathJax_Main;">&gt;</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.829em; vertical-align: -0.115em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-13">></script></span>0.8),</li><li>moderate binding level (PPB = 0.4-0.8)</li><li>low binding level (PPB<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-14-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-112" style="width: 1.017em; display: inline-block;"><span style="display: inline-block; position: relative; width: 0.833em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(2.016em 1000em 2.929em -0.417em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-113"><span class="mo" id="MathJax-Span-114" style="font-family: MathJax_Main;">&lt;</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.829em; vertical-align: -0.115em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-14"><</script></span>0.4).</li></ol><h2 id="human-renal-clearance"><a name="human-renal-clearance" href="#human-renal-clearance"></a>Human Renal Clearance</h2><p>Renal clearance (CLr) plays an important role in the elimination of drugs. While the paper by Chen et al., (<a href="https://dx.doi.org/10.1021/acs.chemrestox.9b00447">https://dx.doi.org/10.1021/acs.chemrestox.9b00447</a>) focuses more on a classification model, we have retained the regression approach.</p><h2 id="rate-of-skin-penetration"><a name="rate-of-skin-penetration" href="#rate-of-skin-penetration"></a>Rate of skin penetration</h2><p>Predicting the rate of transdermal delivery is  required as part of toxicological risk assessments and is important for both pharmaceuticals and the cosmetic industry. The model predicts the permeation rate (<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-15-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-115" style="width: 3.75em; display: inline-block;"><span style="display: inline-block; position: relative; width: 3.111em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.862em 1000em 3.176em -0.474em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-116"><span class="mi" id="MathJax-Span-117" style="font-family: MathJax_Main;">log</span><span class="mo" id="MathJax-Span-118"></span><span class="mtext" id="MathJax-Span-119" style="font-family: MathJax_Main; padding-left: 0.167em;">&nbsp;</span><span class="msubsup" id="MathJax-Span-120"><span style="display: inline-block; position: relative; width: 1.368em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.469em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-121" style="font-family: MathJax_Math; font-style: italic;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.04em;"></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.904em;"><span class="mi" id="MathJax-Span-122" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">p</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.311em; vertical-align: -0.411em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-15">\log\ K_p</script></span>) of chemical compounds through human skin.</p><h2 id="ionization-effect-on-human-skin-permeability"><a name="ionization-effect-on-human-skin-permeability" href="#ionization-effect-on-human-skin-permeability"></a>Ionization effect on human skin permeability</h2><p>The skin permeability of an active ingredient can be impacted by its ionization in a dose solution. The model predicts <em>in vitro</em> human skin permeability coefficients <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-16-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-123" style="width: 3.283em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.722em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.862em 1000em 3.176em -0.474em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-124"><span class="mi" id="MathJax-Span-125" style="font-family: MathJax_Main;">log</span><span class="mo" id="MathJax-Span-126"></span><span class="mtext" id="MathJax-Span-127" style="font-family: MathJax_Main; padding-left: 0.167em;">&nbsp;</span><span class="msubsup" id="MathJax-Span-128"><span style="display: inline-block; position: relative; width: 1.019em; height: 0px;"><span style="position: absolute; clip: rect(1.639em 1000em 2.678em -0.452em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-129" style="font-family: MathJax_Math; font-style: italic;">k</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.556em;"><span class="mi" id="MathJax-Span-130" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">p</span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.311em; vertical-align: -0.411em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-16">\log\ k_p</script></span>.</p><h2 id="skin-sensitization"><a name="skin-sensitization" href="#skin-sensitization"></a>Skin Sensitization</h2><p>Models have beeb developed with <em>in vitro</em>, <em>in chemico</em>, mice and human <em>in vivo</em> data, to predict human effects. Different models were developed for</p><ol>
<li>the direct peptide reactivity assay (DPRA)</li><li>KeratinoSens</li><li>human cell line activation (h-CLAT)</li><li>local lymph node assay (LLNA)</li></ol><h2 id="cancer-potency"><a name="cancer-potency" href="#cancer-potency"></a>Cancer potency</h2><h2 id="carcinogenicity"><a name="carcinogenicity" href="#carcinogenicity"></a>Carcinogenicity</h2><p>The model carcinogenic potency of compounds based on TD<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-17-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-131" style="width: 1.017em; display: inline-block;"><span style="display: inline-block; position: relative; width: 0.833em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.679em 1000em 2.499em -0.5em); top: -2.167em; left: 0em;"><span class="mrow" id="MathJax-Span-132"><span class="msubsup" id="MathJax-Span-133"><span style="display: inline-block; position: relative; width: 0.797em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-134"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -2.128em; left: 0em;"><span class="texatom" id="MathJax-Span-135"><span class="mrow" id="MathJax-Span-136"><span class="mn" id="MathJax-Span-137" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.717em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-17">_{50}</script></span> values of rats and mice. Prior to modelling, the data is converted into pTD50.<br>For the second model, data from the Carcinogenic Potency Database was to distinguish between carcinogens and non-carcinogens.</p><h2 id="metabolic-stability"><a name="metabolic-stability" href="#metabolic-stability"></a>Metabolic Stability</h2><p>The model provides predictions of metabolic stability expressed as T<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-18-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-138" style="width: 0.883em; display: inline-block;"><span style="display: inline-block; position: relative; width: 0.722em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.656em 1000em 2.983em -0.5em); top: -2.167em; left: 0em;"><span class="mrow" id="MathJax-Span-139"><span class="msubsup" id="MathJax-Span-140"><span style="display: inline-block; position: relative; width: 0.713em; height: 0px;"><span style="position: absolute; clip: rect(3.833em 1000em 4.167em -0.5em); top: -4em; left: 0em;"><span class="mi" id="MathJax-Span-141"></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span><span style="position: absolute; top: -3.67em; left: 0em;"><span class="mfrac" id="MathJax-Span-142"><span style="display: inline-block; position: relative; width: 0.398em; height: 0px; margin-right: 0.12em; margin-left: 0.12em;"><span style="position: absolute; clip: rect(1.667em 1000em 2.333em -0.459em); top: -2.508em; left: 50%; margin-left: -0.139em;"><span class="mn" id="MathJax-Span-143" style="font-size: 50%; font-family: MathJax_Main;">1</span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span><span style="position: absolute; clip: rect(1.667em 1000em 2.333em -0.475em); top: -1.846em; left: 50%; margin-left: -0.139em;"><span class="mn" id="MathJax-Span-144" style="font-size: 50%; font-family: MathJax_Main;">2</span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span><span style="position: absolute; clip: rect(0.819em 1000em 1.222em -0.5em); top: -1.202em; left: 0em;"><span style="border-left-width: 0.398em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.25px; vertical-align: 0em;"></span><span style="display: inline-block; width: 0px; height: 1.056em;"></span></span></span></span><span style="display: inline-block; width: 0px; height: 4em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.167em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.327em; vertical-align: -0.847em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-18">_\frac{1}{2}</script></span> (in hours). The cutoffs for metabolic stability class division were as follows:</p><ol>
<li><span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-19-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-145" style="width: 1.017em; display: inline-block;"><span style="display: inline-block; position: relative; width: 0.833em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.92em 1000em 3.027em -0.417em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-146"><span class="mo" id="MathJax-Span-147" style="font-family: MathJax_Main;">≤</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.062em; vertical-align: -0.232em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-19">\leq</script></span> 0.6 - low</li><li>0.6 — 2.32    - medium</li><li><span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-20-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-148" style="width: 1.017em; display: inline-block;"><span style="display: inline-block; position: relative; width: 0.833em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(2.016em 1000em 2.929em -0.417em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-149"><span class="mo" id="MathJax-Span-150" style="font-family: MathJax_Main;">&gt;</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 0.829em; vertical-align: -0.115em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-20">></script></span> 2.32   - high</li></ol><h2 id="steady-state-volume-distribution"><a name="steady-state-volume-distribution" href="#steady-state-volume-distribution"></a>Steady state volume distribution</h2><p>The steady state volume of distribution (<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-21-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-151" style="width: 2.883em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.389em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.824em -0.448em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-152"><span class="mi" id="MathJax-Span-153" style="font-family: MathJax_Math; font-style: italic;">V<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.186em;"></span></span><span class="msubsup" id="MathJax-Span-154"><span style="display: inline-block; position: relative; width: 1.575em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-155" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-156"><span class="mrow" id="MathJax-Span-157"><span class="mi" id="MathJax-Span-158" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">s</span><span class="mi" id="MathJax-Span-159" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">s</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.141em; vertical-align: -0.255em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-21">VD_{ss}</script></span>), is a pharmacokinetic parameter representing an individual drug’s propensity to either remain in the plasma or redistribute to other tissue compartments. </p><ol>
<li>High <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-22-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-160" style="width: 2.883em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.389em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.824em -0.448em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-161"><span class="mi" id="MathJax-Span-162" style="font-family: MathJax_Math; font-style: italic;">V<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.186em;"></span></span><span class="msubsup" id="MathJax-Span-163"><span style="display: inline-block; position: relative; width: 1.575em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-164" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-165"><span class="mrow" id="MathJax-Span-166"><span class="mi" id="MathJax-Span-167" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">s</span><span class="mi" id="MathJax-Span-168" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">s</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.141em; vertical-align: -0.255em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-22">VD_{ss}</script></span> : More distribution to other tissue</li><li>Low <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-23-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-169" style="width: 2.883em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.389em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.824em -0.448em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-170"><span class="mi" id="MathJax-Span-171" style="font-family: MathJax_Math; font-style: italic;">V<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.186em;"></span></span><span class="msubsup" id="MathJax-Span-172"><span style="display: inline-block; position: relative; width: 1.575em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-173" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-174"><span class="mrow" id="MathJax-Span-175"><span class="mi" id="MathJax-Span-176" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">s</span><span class="mi" id="MathJax-Span-177" style="font-size: 70.7%; font-family: MathJax_Math; font-style: italic;">s</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.141em; vertical-align: -0.255em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-23">VD_{ss}</script></span>  : Less distribution to other tissue</li></ol><h2 id="$$ld_{50}$$-rat-acute-oral-toxicity"><a name="$$ld_{50}$$-rat-acute-oral-toxicity" href="#$$ld_{50}$$-rat-acute-oral-toxicity"></a><span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-24-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-178" style="width: 2.817em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.333em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.832em -0.468em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-179"><span class="mi" id="MathJax-Span-180" style="font-family: MathJax_Math; font-style: italic;">L</span><span class="msubsup" id="MathJax-Span-181"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-182" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-183"><span class="mrow" id="MathJax-Span-184"><span class="mn" id="MathJax-Span-185" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-24">LD_{50}</script></span> rat acute oral toxicity</h2><p>The median lethal dose for rodent oral acute toxicity (<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-25-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-186" style="width: 2.817em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.333em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.832em -0.468em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-187"><span class="mi" id="MathJax-Span-188" style="font-family: MathJax_Math; font-style: italic;">L</span><span class="msubsup" id="MathJax-Span-189"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-190" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-191"><span class="mrow" id="MathJax-Span-192"><span class="mn" id="MathJax-Span-193" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-25">LD_{50}</script></span>) is required to categorize chemicals in terms of the potential hazard posed to human health after acute exposure. Here we use the EPA hazard classification<br>EPA’s 4-category hazard classification [20]:</p><ol>
<li>Category I (<span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-26-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-194" style="width: 4.083em; display: inline-block;"><span style="display: inline-block; position: relative; width: 3.389em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.873em 1000em 3.054em -0.468em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-195"><span class="mi" id="MathJax-Span-196" style="font-family: MathJax_Math; font-style: italic;">L</span><span class="msubsup" id="MathJax-Span-197"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-198" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-199"><span class="mrow" id="MathJax-Span-200"><span class="mn" id="MathJax-Span-201" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span><span class="mo" id="MathJax-Span-202" style="font-family: MathJax_Main; padding-left: 0.278em;">≤</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-26">LD_{50} \leq </script></span> 50 mg/kg) is the highest toxicity category.</li><li>Category II (moderately toxic) includes chemicals with 50 &lt; <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-27-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-203" style="width: 6.217em; display: inline-block;"><span style="display: inline-block; position: relative; width: 5.167em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.873em 1000em 3.054em -0.468em); top: -2.722em; left: 0em;"><span class="mrow" id="MathJax-Span-204"><span class="mi" id="MathJax-Span-205" style="font-family: MathJax_Math; font-style: italic;">L</span><span class="msubsup" id="MathJax-Span-206"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-207" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-208"><span class="mrow" id="MathJax-Span-209"><span class="mn" id="MathJax-Span-210" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span><span class="mo" id="MathJax-Span-211" style="font-family: MathJax_Main; padding-left: 0.278em;">≤</span><span class="mn" id="MathJax-Span-212" style="font-family: MathJax_Main; padding-left: 0.278em;">500</span></span><span style="display: inline-block; width: 0px; height: 2.722em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-27">LD_{50} \leq 500</script></span> mg/kg.</li><li>Category III (slightly toxic) includes chemicals with 500 &lt; <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-28-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-213" style="width: 2.817em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.333em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.832em -0.468em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-214"><span class="mi" id="MathJax-Span-215" style="font-family: MathJax_Math; font-style: italic;">L</span><span class="msubsup" id="MathJax-Span-216"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-217" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-218"><span class="mrow" id="MathJax-Span-219"><span class="mn" id="MathJax-Span-220" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-28">LD_{50}</script></span> ≤ 5000 mg/kg. Safe chemicals</li><li><span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-29-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-221" style="width: 2.817em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.333em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.832em -0.468em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-222"><span class="mi" id="MathJax-Span-223" style="font-family: MathJax_Math; font-style: italic;">L</span><span class="msubsup" id="MathJax-Span-224"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-225" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-226"><span class="mrow" id="MathJax-Span-227"><span class="mn" id="MathJax-Span-228" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-29">LD_{50}</script></span> &gt; 5000 mg/kg are included in Category IV.</li></ol><h2 id="ames-mutagenecity"><a name="ames-mutagenecity" href="#ames-mutagenecity"></a>AMES mutagenecity</h2><p>Mutagenecity is a prime indicator of toxicity that can cause mutations in the DNA of the test organism. The model predicts whether the compound is mutagenic or not.</p><h2 id="cytotoxicity"><a name="cytotoxicity" href="#cytotoxicity"></a>Cytotoxicity</h2><p>Cytotoxicity is the degree to which a compound causes damage to cells. Numerous assays are used to screen compounds, and in this study models for different assays have been analysed</p><ol>
<li><em>in vitro</em> toxicity against HepG2 cells</li><li>Human embryonic kidney 293 cell (HEK 293)</li><li>NIH/3T3</li><li>CRL-7250</li><li>HaCat</li></ol><h2 id="drug-induced-liver-injury-(dili)"><a name="drug-induced-liver-injury-(dili)" href="#drug-induced-liver-injury-(dili)"></a>Drug induced Liver injury (DILI)</h2><p>Early stage discovery of DILI is much desired. The classification model focuses on distinguishing between DILI-positive and DILI-negative compounds. DILI has several manifestations:</p><ol>
<li>Drug-induced Choleostasis: Cholestatic liver injury i.e. cholestasis, is the disruption of the bile flow</li><li>Drug-induced toxic myopathy (rare adverse drug reaction) can cause skeletal muscle damage and pain. Another related muscle related issue is that of frug-induced rhabdomyolysis which causes death of muscle fibers and release of their contents into the bloodstream.</li><li>Hemolytic Toxicity: This form of toxicity can cause lysis of the erythrocyte membrane and subsequent release of hemoglobin into blood plasma, leading to multiple acute and chronic adverse effects. Two models have been proposed<ol>
<li>Prediction of hemolytic toxicity of small molecules with experimental values of <span><span class="MathJax_Preview"></span><span class="MathJax" id="MathJax-Element-30-Frame" role="textbox" aria-readonly="true"><nobr><span class="math" id="MathJax-Span-229" style="width: 3.083em; display: inline-block;"><span style="display: inline-block; position: relative; width: 2.556em; height: 0px; font-size: 120%;"><span style="position: absolute; clip: rect(1.65em 1000em 2.832em -0.469em); top: -2.5em; left: 0em;"><span class="mrow" id="MathJax-Span-230"><span class="mi" id="MathJax-Span-231" style="font-family: MathJax_Math; font-style: italic;">H<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.057em;"></span></span><span class="msubsup" id="MathJax-Span-232"><span style="display: inline-block; position: relative; width: 1.631em; height: 0px;"><span style="position: absolute; clip: rect(1.65em 1000em 2.667em -0.467em); top: -2.5em; left: 0em;"><span class="mi" id="MathJax-Span-233" style="font-family: MathJax_Math; font-style: italic;">D</span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span><span style="position: absolute; top: -2.128em; left: 0.833em;"><span class="texatom" id="MathJax-Span-234"><span class="mrow" id="MathJax-Span-235"><span class="mn" id="MathJax-Span-236" style="font-size: 70.7%; font-family: MathJax_Main;">50</span></span></span><span style="display: inline-block; width: 0px; height: 2.278em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.5em;"></span></span></span><span style="border-left-width: 0em; border-left-style: solid; display: inline-block; overflow: hidden; width: 0px; height: 1.152em; vertical-align: -0.265em;"></span></span></nobr></span><script type="math/tex" id="MathJax-Element-30">HD_{50}</script></span></li><li>hemolytic toxicity of saponins</li></ol>
</li><li>Drug-induced myelotoxicity usually leads to decrease the production of platelets, red cells, and white cells.</li><li>Mitochondrial Toxicity: Mitochondria play a central role in maintaining cellular homeostasis. A side effect of certain antiretroviral drugs causes the mitochondria of a body’s cells to become damaged or decline significantly in number. The model predicts whether a drug is a mitochondrial toxic compounds or negatives (i. e. Non-mitochondrial toxic compounds).</li><li>Drug-induced ototoxicity: Some drugs currently in clinical use can cause cellular degeneration of cochlear and/or vestibular system, leading to temporary or permanent hearing loss or other ear problems. The model distinguishes between ototoxicants and non-toxicants.</li><li>Respiratory Toxicity: Drug-induced respiratory toxicity can cause significant toxicological issues. Cclinical symptoms mainly include wheezing, bronchoconstriction, asthmatic attacks and pulmonary eosinophilia.</li><li>Drug Phototoxicity: Photosensitization is a significant safety concern for drug development in certain chronic disease indications where patients are exposed to sunlight. Drug photosensitization (photoirritation/photoallergy) can result in side effects such as rashes or dermatitis.  Here we focus on two models:<ol>
<li><em>in vitro</em> phototoxicity (3T3 NRU phototoxicity reports)</li><li>human photosensitization (clinical photosensitization alerts)</li></ol>
</li><li>Urinary tract toxicity, especially nephrotoxicity is the poisonous effect of some substances, both toxic chemicals and medications, on kidney function.  According to the regulation of U.S. Environmental Protection Agency, compounds<br>were categorized into two classes: <ol>
<li>Compounds with LD50 500 mg/kg were defined as urinary tract toxicants</li><li>Compounds with LD50 &gt; 500 mg/kg were set as urinary tract non-toxicants</li></ol>
</li><li>Phospholipidosis: The drug-induced accumulation of phospholipids in lysosomes of various tissues is predominantly observed after prolonged exposure. </li><li>Hepatic Steatosis: Fatty liver also known as hepatic steatosis, occurs when fat builds up in the liver. It is a rare form of DILI.</li></ol><h2 id="herg-induced-cardiotoxicity"><a name="herg-induced-cardiotoxicity" href="#herg-induced-cardiotoxicity"></a>hERG-induced cardiotoxicity</h2><h2 id="herg-liability"><a name="herg-liability" href="#herg-liability"></a>hERG liability</h2><p>Blockade of the human ether-à-go-go-related gene (hERG) channel by small molecules leads to fatal cardiotoxicity. The binary classification model is used for cardiotoxic risk assessment.<br>A second model is used to discriminate potential hERG blockers from non-blockers.</p>

<footer style="position:fixed; font-size:.8em; text-align:right; bottom:0px; margin-left:-25px; height:20px; width:100%;">generated by <a href="http://pad.haroopress.com" target="_blank">haroopad</a></footer>
</body>
</html>
